Biofidelity Aspyre Lung Reagents

Biofidelity has launched Aspyre Lung Reagents for research use only in liquid biopsy samples. Aspyre Lung identifies established non-small cell lung cancer (NSCLC) biomarkers in both DNA and RNA from tissue and blood in a four-step workflow and runs on existing qPCR platforms. Data supporting the launch will be presented at the Association for Molecular Pathology Annual Meeting next week in Vancouver, British Columbia.